Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (371-380 of 382) with videos related to

Pageof 39
Sort By:
Journal of the American College of Cardiology|January 29, 2021
Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection FractionMichael Frisk, Christopher Le, Xin Shen, et al.
Nature Communications|February 5, 2025
Testosterone exacerbates neutrophilia and cardiac injury in myocardial infarction via actions in bone marrowElin Svedlund Eriksson, Marta Lantero Rodriguez, Bente Halvorsen, et al.
European Heart Journal|December 22, 2020
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetesWilliam T Abraham, JoAnn Lindenfeld, Piotr Ponikowski, et al.
Ebiomedicine|October 12, 2025
The effects of interleukin-6-receptor inhibition on monocytes in STEMI: a substudy of the ASSAIL-MI trialCamilla Huse, Sarah Louise Murphy, Kuan Yang, et al.
Ebiomedicine|May 3, 2022
Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trialCamilla Huse, Anne Kristine Anstensrud, Annika E Michelsen, et al.
Atherosclerosis|December 25, 2019
Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophagesNgoc Nguyen Lunde, Ida Gregersen, Thor Ueland, et al.
European Journal of Heart Failure|March 1, 2018
Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetesFranco Cosmi, Li Shen, Michela Magnoli, et al.
Cell Reports|January 5, 2017
NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial RuptureMaria B Olsen, Gunn A Hildrestrand, Katja Scheffler, et al.
The New England Journal of Medicine|November 17, 2019
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve ReplacementGeorge D Dangas, Jan G P Tijssen, Jochen Wöhrle, et al.
European Journal of Heart Failure|January 11, 2020
Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin TAlberto Aimo, James L Januzzi, Giuseppe Vergaro, et al.
Pageof 39

Showing results (371-380 of 382) with videos related to

Sort By:
Pageof 39
Journal of the American College of Cardiology|January 29, 2021
Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection FractionMichael Frisk, Christopher Le, Xin Shen, et al.
Nature Communications|February 5, 2025
Testosterone exacerbates neutrophilia and cardiac injury in myocardial infarction via actions in bone marrowElin Svedlund Eriksson, Marta Lantero Rodriguez, Bente Halvorsen, et al.
European Heart Journal|December 22, 2020
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetesWilliam T Abraham, JoAnn Lindenfeld, Piotr Ponikowski, et al.
Ebiomedicine|October 12, 2025
The effects of interleukin-6-receptor inhibition on monocytes in STEMI: a substudy of the ASSAIL-MI trialCamilla Huse, Sarah Louise Murphy, Kuan Yang, et al.
Ebiomedicine|May 3, 2022
Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trialCamilla Huse, Anne Kristine Anstensrud, Annika E Michelsen, et al.
Atherosclerosis|December 25, 2019
Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophagesNgoc Nguyen Lunde, Ida Gregersen, Thor Ueland, et al.
European Journal of Heart Failure|March 1, 2018
Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetesFranco Cosmi, Li Shen, Michela Magnoli, et al.
Cell Reports|January 5, 2017
NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial RuptureMaria B Olsen, Gunn A Hildrestrand, Katja Scheffler, et al.
The New England Journal of Medicine|November 17, 2019
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve ReplacementGeorge D Dangas, Jan G P Tijssen, Jochen Wöhrle, et al.
European Journal of Heart Failure|January 11, 2020
Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin TAlberto Aimo, James L Januzzi, Giuseppe Vergaro, et al.
Pageof 39